🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
Developing novel CAR T cell designs using combinatorial antigen detection
Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 Apr 2021Deadline 31 Mar 2026 ⚠️
NIHUS FederalResearch GrantFY2025Antigen TargetingAntigensB cell malignancyB lymphoid malignancyB lymphomaB-Cell LymphomasBioinformaticsBiometricsBiometryBiostatisticsCAR T cellsCAR modified T cellsCAR-TCAR-TsCaliforniaCancersCell BodyCell Communication and SignalingCell SignalingCell Surface AntigensCell TherapyCell-Mediated Lympholytic CellsCellsClinicalClinical Trials DesignComprehensive Cancer CenterCross ReactionsCytolytic T-CellCytotoxic T CellCytotoxic T-LymphocytesData CollectionDedicationsDepartment chairDetectionDiseaseDisorderDoctor of PhilosophyEcologic SystemsEcological SystemsEcosystemEngineeringEnvironmentFacultyFibroblastsFoundationsGene Down-RegulationGenerationsGenetic EngineeringGenetic Engineering BiotechnologyGenetic Engineering Molecular BiologyGoalsImmune mediated therapyImmune systemImmunocompetentImmunological Surface MarkersImmunologically Directed TherapyImmunotherapyIntracellular Communication and SignalingInvestigatorsKnowledgeLaboratoriesLeadLogicMacrophageMalignant NeoplasmsMalignant Pancreatic NeoplasmMalignant TumorMalignant neoplasm of pancreasMeasuresMedical OncologistMedical OncologyMentorsMentorshipMiceMice MammalsMolecularMurineMusMφNerve CellsNerve UnitNeural CellNeuroblastomaNeurocyteNeuronsNormal CellNormal TissueNormal tissue morphologyOrganPancreas AdenocarcinomaPancreas CancerPancreas Ductal AdenocarcinomaPancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal AdenocarcinomaPatientsPb elementPh.D.PhDPharmacologyPhysiciansPositionPositioning AttributePostdocPostdoctoral FellowProductionProteinsReceptor ProteinRecombinant DNA TechnologyResearchResearch AssociateResearch PersonnelResearchersSafetySan FranciscoScientistSignal TransductionSignal Transduction SystemsSignalingSolidSolid NeoplasmSolid TumorSoluble Mpf/Mesothelin-Related ProteinSurface AntigensSynthetic immunologySystemT cells for CARTestingTherapeuticToxic effectToxicitiesTrainingTranscription RepressionTranslational Research EnterpriseTranslationsTreatment EfficacyTumor AntigensTumor CellTumor TissueTumor-Associated AntigenTwin Multiple BirthTwinsUniversitiesWorkanti-cancer immunotherapyanticancer immunotherapyantigen based detectionantigen detectionbiological signal transductioncancer antigenscancer immunologycancer immunotherapycancer microenvironmentcareer developmentcell based interventioncell engineeringcell mediated interventioncell mediated therapiescell typecell-based therapeuticcell-based therapycellular engineeringcellular therapeuticcellular therapychimeric antigen T cell receptorchimeric antigen receptorchimeric antigen receptor (CAR) T cellschimeric antigen receptor Tchimeric antigen receptor T cellschimeric antigen receptor fusion protein T-cellschimeric antigen receptor modified T cellsclinical practicecombinatorialcross reactivitycytokinedesigndesigningdetect antigenearly clinical trialearly phase clinical trialearly phase trialeffective therapyeffective treatmentengineered T cellsexperiencegene repressiongenetically engineeredgenetically engineered T-cellsheavy metal Pbheavy metal leadimmune competentimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based cancer therapiesimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimmunotherapy for cancerimmunotherapy of cancerimprovedintervention efficacykiller T cellleukemia/lymphomalymphoma/leukemiamalignancymesothelinmouse modelmurine modelneoplasm immunologyneoplasm/cancerneoplastic cellneuron toxicityneuronalneuronal toxicityneurotoxicitynew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generationnext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypancreatic cancer modelpancreatic malignancypancreatic tumor modelpost-docpost-doctoralpost-doctoral traineepreventpreventingprofessorprogramsreceptorreceptor expressionresearch associatessuccesssynthetic biologytherapeutic efficacytherapy efficacytooltransgenic T- cellstranslationtranslation research enterprisetranslational immunologytranslational research programtumortumor immunologytumor microenvironmenttumor-specific antigen
Applications closed.
Description preview
PROJECT SUMMARY/ABSTRACT
Candidate: The applicant, Greg Allen, MD/PhD, is a medical oncologist at UCSF with a long-term goal to lead
an independent laboratory-based translational research program focused on cellular therapies. The K08
application is key for his career development, providing him with (1) mentorship from a diverse team of scientists…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click